Copied
 
 
Formål
Formål
Selskabets formål at udvikle dokumenteret medicin til humant brug med hoved- fokus på børn samt al virksomhed, som efter bestyrelsens skøn har forbindelse hermed.
Sidst opdateret den 14.04.2020 og angivet som gældende fra 06.04.2020 (1482 dage).
Ingen historik.
Status
Virksomhedsstatus
NORMAL.
Sidst opdateret den 14.04.2020 og angivet som gældende fra 15.04.2020 (1473 dage).
HistorikStartStop
NORMAL15.04.2020
UDEN RETSVIRKNING06.04.202014.04.2020
Branche
Branche
Fremstilling af farmaceutiske præparater (212000).
Sidst opdateret den 14.04.2020 og angivet som gældende fra 06.04.2020 (1482 dage).
Ingen historik.
Revision
Revisionfravalgt
false.
Sidst opdateret den 14.04.2020 og angivet som gældende fra 06.04.2020 (1482 dage).
Ingen historik.
Revisor
Revisor
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
Sidst opdateret den 29.09.2020 og angivet som gældende fra 18.08.2020 (1348 dage).
Form
Virksomhedsform
60.
Sidst opdateret den 25.08.2020 og angivet som gældende fra 18.08.2020 (1348 dage).
HistorikStartStop
6018.08.2020
8006.04.202017.08.2020
Kontakt
Kontaktoplysninger
jes.trygved@cessatech.com.
Sidst opdateret den 01.12.2020 og angivet som gældende fra 01.12.2020 (1243 dage).
HistorikStartStop
jes.trygved@cessatech.com01.12.2020
jes.trygved@gmail.com15.04.202030.11.2020
Telefon
Telefonnummer
93872309.
Sidst opdateret den 14.04.2020 og angivet som gældende fra 15.04.2020 (1473 dage).
Ingen historik.
Navne
Tegningsregel
Tegningsregel
Selskabet tegnes af bestyrelsesformanden og en direktør i forening eller af den samlede bestyrelse.
Sidst opdateret den 14.04.2020 og angivet som gældende fra 06.04.2020 (1482 dage).
Fortolkning (2 tegningsmuligheder)
formanden + 1 direktør
bestyrelsen
Ingen historik.
Ansatte
27.04.2024
Ingen historik.
Kapital
27.04.2024
Fra årsrapport
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:33771231
Beskrivelse af revisor:State Authorised Public Accountant
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):Basis for OpinionWe conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Ourresponsibilities under those standards and requirements are further described in the Auditor’s Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):OpinionIn our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2023, and of the results of theCompany’s operations and cash flows for the financial year 1 January - 31 December 2023 in accordance with IFRS accounting standards as adopted by the EU and further requirements in the Danish Financial Statements Act. We have audited the Financial Statements of Cessatech A/S for the financial year 1 January - 31 December 2023, which comprise income statement andstatement of comprehensive income, balance sheet, statement of cash flows, statement of changes in equity and notes, including a summary of significant accounting policies (“financial statements”).
Udtalelse om ledelsesberetningen (revision):Statement on Management’s ReviewManagement is responsible for Management’s Review. Our opinion on the financial statements døs not cover Management’s Review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read Management’s Review and, in doing so, consider whether Management’s Review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether Management’s Review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, in our view, Management’s Review is in accordance with the Financial Statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement in Management’s Review.
Bibranche
Ingen nuværende registrering.
Ingen historik.
Børsnoteret
27.04.2024
Ingen nuværende registrering.
Ingen historik.
Hjemmeside
27.04.2024
Hjemmeside
www.cessatech.com.
Sidst opdateret den 14.04.2020 og angivet som gældende fra 06.04.2020 (1482 dage).
Ingen historik.